Focused on novel, nanotechnology-based therapeutics
Oliver Fetzer, Ph.D.
President and Chief Executive Officer
David P. DeMagistris, Ph.D.
Senior Vice President, Pharmaceutical Sciences and Manufacturing
Scott Eliasof, Ph.D.
Senior Director, Research
Alexandra Glucksmann, Ph.D.
Senior Vice President, Research and Business Operations
Senior Vice President, Finance and Administration
Karen joins Cerulean after serving as Vice President, Finance and Administration at Elixir Pharmaceuticals, Inc., since the Company’s founding in 2001. At Elixir, Karen was a core member of the executive management team, responsible for all aspects of accounting, finance and administration for the Company. Prior to joining Elixir, Karen held senior financial positions where she was responsible for financial operations at Frontline Group, Dyax Corporation and T Cell Sciences. Karen was recruited into life sciences from Avery Dennison, where she held numerous financial positions of increasing responsibility.
Karen is a member of the Financial Executives Institute – Boston Chapter and holds a BS in Business Administration from Salem State College.
John Ryan, Ph.D., M.D.
Senior Vice President and Chief Medical Officer
Jean Silveri, J.D.
Senior Vice President, General Counsel
Senior Director, Pharmaceutical Sciences and Manufacturing
Cissy Young, Ph.D.
Director, Strategy and Business Development